Practical application of a calculator for conditional survival in colon cancer

Journal of Clinical Oncology

Volumn 27, Issue 35, 2009, Pages 5938-5943

  Chang, George J ^a   Hu, Chung Yuan ^a   Eng, Cathy ^a   Skibber, John M ^a   Rodriguez Bigas, Miguel A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CALCULATOR; CANCER GRADING; CANCER PATIENT; CANCER REGISTRY; CANCER SURVIVAL; COLON ADENOCARCINOMA; COLON CANCER; DECISION MAKING; ETHNICITY; EXPECTANCY; FEMALE; FOLLOW UP; HEALTH CARE PLANNING; HUMAN; INTERNET; LIFE; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; OUTCOME ASSESSMENT; PHYSICIAN; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; SEX DIFFERENCE; ADENOCARCINOMA; CANCER STAGING; COLON TUMOR; EVALUATION; HEALTH SURVEY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOLOGY; PREDICTION AND FORECASTING; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; FEMALE; HEALTH STATUS INDICATORS; HUMANS; INTERNET; KAPLAN-MEIERS ESTIMATE; LINEAR MODELS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEER PROGRAM; TIME FACTORS; TREATMENT OUTCOME;

EID: 73349097906     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.23.1860     Document Type: Article

References (25)

1. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2008. CA Cancer J Clin 58:71-96, 2008
2. Ferrell BR, Dow KH, Leigh S, et al: Quality of life in long-term cancer survivors. Oncol Nurs Forum 22:915-922, 1995
3. Choi M, Fuller CD, Thomas CR Jr, et al: Conditional survival in ovarian cancer: Results from the SEER dataset 1988-2001. Gynecol Oncol 109: 203-209, 2008
4. Fuller CD, Wang SJ, Thomas CR Jr, et al: Conditional survival in head and neck squamous cell carcinoma: Results from the SEER dataset 1973-1998. Cancer 109:1331-1343, 2007
5. Kato I, Severson RK, Schwartz AG: Conditional median survival of patients with advanced carcinoma: Surveillance, epidemiology, and end results data. Cancer 92:2211-2219, 2001
6. Merrill RM, Henson DE, Ries LA: Conditional survival estimates in 34,963 patients with invasive carcinoma of the colon. Dis Colon Rectum 41:1097-1106, 1998
7. Wang SJ, Emery R, Fuller CD, et al: Conditional survival in gastric cancer: A SEER database analysis. Gastric Cancer 10:153-158, 2007
8. Surveillance, Epidemiology, and End Results (SEER): SEER Program Limited-Use Data, 1973-2005. National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, Bethesda, MD, 2008
9. Reference deleted
10. Moertel CG, Fleming TR, Macdonald JS, et al: Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322:352-358, 1990
11. Laurie JA, Moertel CG, Fleming TR, et al: Surgical adjuvant therapy of large-bowel carcinoma: An evaluation of levamisole and the combination of levamisole and fluorouracil-The North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol 7:1447-1456, 1989
12. Schoenfeld D: Partial residuals for the proportional hazards regression model. Biometrika 69:239-241, 1982
13. Freedman AN, Seminara D, Gail MH, et al: Cancer risk prediction models: A workshop on development, evaluation, and application. J Natl Cancer Inst 97:715-723, 2005
14. Harrell FE Jr, Califf RM, Pryor DB, et al: Evaluating the yield of medical tests. JAMA 247: 2543-2546, 1982
15. Harrell FE Jr, Lee KL, Mark DB: Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361-387, 1996
16. O'Connell JB, Maggard MA, Ko CY: Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 96:1420-1425, 2004
17. Le H, Ziogas A, Lipkin SM, et al: Effects of socioeconomic status and treatment disparities in colorectal cancer survival. Cancer Epidemiol Biomarkers Prev 17:1950-1962, 2008
18. Coleman MP, Quaresma M, Berrino F, et al: Cancer survival in five continents: A worldwide population-based study (CONCORD). Lancet Oncol 9:730-756, 2008
19. Alfano CM, Rowland JH: Recovery issues in cancer survivorship: A new challenge for supportive care. Cancer J 12:432-443, 2006
20. Kattlove H, Winn RJ: Ongoing care of patients after primary treatment for their cancer. CA Cancer J Clin 53:172-196, 2003
21. Spencer SM, Lehman JM, Wynings C, et al: Concerns about breast cancer and relations to psychosocial well-being in a multiethnic sample of earlystage patients. Health Psychol 18:159-168, 1999
22. Mellon S, Kershaw TS, Northouse LL, et al: A family-based model to predict fear of recurrence for cancer survivors and their caregivers. Psychooncology 16:214-223, 2007
23. Wang SJ, Fuller CD, Kim JS, et al: Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer. J Clin Oncol 26:2112-2117, 2008
24. Sargent D, Sobrero A, Grothey A, et al: Evidence for cure by adjuvant therapy in colon cancer: Observations based on individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 27:872-877, 2009
25. Kopetz S, Chang GJ, Overman MJ, et al: Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 27:3677-3683, 2009